Literature DB >> 15578261

The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.

Frédéric G Sala1, Pierre-Marie Del Moral, Nathalie Pizzato, Florence Legrand-Abravanel, Philippe Le Bouteiller, Françoise Lenfant.   

Abstract

HLA-G is a non-classical HLA class Ib molecule primarily expressed in trophoblast cells, and is thought to play a key role in the induction of materno-fetal tolerance during pregnancy. In addition, the HLA-G gene provides a suitable leader sequence peptide capable of binding to HLA-E. However, the existence of placentas homozygous for the HLA-G*0105N null allele suggests that HLA-G1 might not be essential for fetal survival. To investigate whether expression of the HLA-G*0105N allele supports HLA-E cell surface expression, we transfected the HLA-G*0105N gene into JAR trophoblast cells. Flow cytometry analysis showed that HLA-G*0105N-transfected cells express surface HLA-E to a similar extent as the unmutated HLA-G gene, whereas HLA-G1 cell surface expression was undetectable. Using the NKL cell line in a standard (51)Cr release assay, the HLA-E molecules were found to inhibit natural killer lysis, through a mechanism partially dependent on CD94/NKG2A-mediated recognition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578261     DOI: 10.1007/s00251-004-0733-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  34 in total

1.  Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.

Authors:  S Fournel; M Aguerre-Girr; X Huc; F Lenfant; A Alam; A Toubert; A Bensussan; P Le Bouteiller
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.

Authors:  J Boucraut; T Guillaudeux; M Alizadeh; J Boretto; G Chimini; F Malecaze; G Semana; R Fauchet; P Pontarotti; P Le Bouteiller
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.

Authors:  S Agrawal; J Marquet; G J Freeman; A Tawab; P L Bouteiller; P Roth; W Bolton; G Ogg; L Boumsell; A Bensussan
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

4.  Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast.

Authors:  A King; C Boocock; A M Sharkey; L Gardner; A Beretta; A G Siccardi; Y W Loke
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

5.  Nonclassical HLA-G molecules are classical peptide presenters.

Authors:  M Diehl; C Münz; W Keilholz; S Stevanović; N Holmes; Y W Loke; H G Rammensee
Journal:  Curr Biol       Date:  1996-03-01       Impact factor: 10.834

6.  Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product.

Authors:  A Aiyar; J Leis
Journal:  Biotechniques       Date:  1993-03       Impact factor: 1.993

7.  The HLA-G gene is expressed at a low mRNA level in different human cells and tissues.

Authors:  M Onno; T Guillaudeux; L Amiot; I Renard; B Drenou; B Hirel; M Girr; G Semana; P Le Bouteiller; R Fauchet
Journal:  Hum Immunol       Date:  1994-09       Impact factor: 2.850

8.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

Authors:  M J Robertson; K J Cochran; C Cameron; J M Le; R Tantravahi; J Ritz
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

9.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

Authors:  T Fujii; A Ishitani; D E Geraghty
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Authors:  M Colonna; F Navarro; T Bellón; M Llano; P García; J Samaridis; L Angman; M Cella; M López-Botet
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia.

Authors:  Fangyuan Luo; Jun Yue; Lingling Li; Jie Mei; Xinghui Liu; Yu Huang
Journal:  Ann Transl Med       Date:  2022-06

2.  Spontaneous regression of gestational trophoblastic neoplasia.

Authors:  Kaoru Niimi; Eiko Yamamoto; Kimihiro Nishino; Sawako Fujiwara; Kazuhiko Ino; Fumitaka Kikkawa
Journal:  Gynecol Oncol Rep       Date:  2017-07-25

Review 3.  Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

Review 4.  Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Front Immunol       Date:  2014-08-22       Impact factor: 7.561

5.  Frequency of null allele of Human Leukocyte Antigen-G (HLA-G) locus in subjects to recurrent miscarriage.

Authors:  Nazila Alizadeh; Elnaz Mosaferi; Laya Farzadi; Jafar Majidi; Amir Monfaredan; Bahman Yousefi; Behzad Baradaran
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.